注射给药市场：按设备类型、材料类型、性别、给药途径、最终用户和地区划分

预计到 2026 年，注射给药市场规模将达到 6,500 亿美元，到 2033 年将达到 9,000 亿美元，2026 年至 2033 年的复合年增长率为 7%。

注射剂可将药物直接输送到作用部位，从而最大限度地提高生物利用度并避免首过效应。注射剂主要用于口服困难或稳定性较差的药物。对于意识不清的患者或口服药片和胶囊依从性差的患者，注射给药可能是合适的选择。

市场动态

糖尿病、心臟病和过敏性休克等慢性疾病的日益普遍推动了全球注射给药市场的成长。根据《过敏、气喘与临床免疫学杂誌》报道，截至2015年，英国约有1,500万人患有食物过敏。同样，欧洲过敏与临床免疫学会（EAACI）报告称，截至2015年，英国约有1700万人患有食物过敏，其中约350万为儿童。日益增强的安全意识和对针刺伤的担忧是推动注射给药市场成长的关键因素。例如，世界卫生组织建议使用具有锐器损伤预防（SIP）功能的安全注射器来预防针扎伤。同样，2017年5月，Innovative Neurons LLC宣布其名为FAST（快速、便利、安全且技术先进）的取得专利的自动伸缩多针注射器实现商业化，旨在减少针刺伤。众多市场相关人员正致力于该领域的研发与进步。例如，辉瑞公司推出的ACT-O-VIAL系统是一种双组分管瓶系统，只需按压塑胶盖即可復溶无菌注射剂。市场参与者推出的以患者为中心的设施预计将推动市场成长。例如，2018年7月，辉瑞宣布将在美国密西根州建造一座无菌注射剂生产设施。

然而，在预测期内限制市场发展的主要因素将是製造商的产品召回。例如，2018年4月，贝克顿·迪克森公司宣布召回其PosiFlush肝素封管冲洗注射器和预填充生理食盐水注射器，原因是这些产品受到黏质沙雷氏菌的污染。

本次调查的主要特点

• 本报告对注射药物输送市场进行了详细分析，以 2017 年为基准年，给出了预测期（2018-2026 年）内的市场规模和复合年增长率（%）。
• 该报告重点介绍了各个细分市场的潜在商机，并为该市场说明了一个引人注目的投资提案矩阵。
• 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要企业的竞争策略的重要见解。
• 该研究根据公司概况、财务表现、产品系列、市场占有率、分销策略、关键发展、策略和未来计划等参数，对全球注射药物输送市场的主要企业进行了分析。
• 本报告的研究结果将使负责人和经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
• 这份全球注射药物输送市场报告的目标受众包括该行业的各类相关人员，例如投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员将能够透过用于分析全球注射药物输送市场的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

• 调查目的
• 先决条件
• 简称

第二章 市场概览

• 报告概述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、监理及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 法规环境
• 产品上市及核准情况
• PEST分析
• 波特分析
• 市场机会
• 法规环境
• 重大进展
• 产业趋势

4. 2020-2033年全球注射给药市场（依器材类型划分）

• 预填充式注射器
• 自动注射器
• 笔型
• 普通注射器
• 墨水匣
• 安瓿
• 管瓶
• 其他的

5. 2020-2033年全球注射药物传输市场（依材料类型划分）

• 玻璃
• 塑胶

6. 2020-2033年全球注射给药市场（依使用者性别划分）

• 一次性的
• 可重复使用的

7. 2020-2033年全球注射给药市场（依给药途径划分）

• 静脉
• 肌肉内注射
• 皮下

8. 2020-2033年全球注射药物传输市场（依最终用户划分）

• 医院
• 诊所
• 门诊手术中心
• 居家医疗
• 其他的

9. 2020-2033年全球注射给药市场（依地区划分）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲国家
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 北非
  • 中非

第十章 竞争格局

• Becton, Dickinson and Company
• Pfizer Inc.
• Novo Nordisk A/S
• Gerresheimer AG
• Carl-Zeiss-Stiftung
• Terumo Corporation
• Vetter Pharma-Fertigung GmbH &Co. KG
• SHL Group
• Owen Mumford Limited
• Injex Pharma GmbH

第十一章 分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十二章 参考文献与调查方法

• 参考
• 调查方法
• 关于本公司

Injectable Drug Delivery Market is estimated to be valued at USD 650 Bn in 2026 and is expected to reach USD 900 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7% from 2026 to 2033.

Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can't be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.

Market Dynamics

Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S.

However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium.

Key features of the study

• This report provides in-depth analysis of the injectables drug delivery market and provides market size (USD million) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global injectable drug delivery market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
• The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market

Market Segmentation

• Device Type Insights (Revenue, USD Bn, 2026 - 2033)
  • Prefilled Syringes
  • Auto Injectors
  • Pens
  • Conventional Syringes
  • Cartridges
  • Ampoules
  • Vials
  • Others
• Material Type Insights (Revenue, USD Bn, 2026 - 2033)
  • Glass
  • Plastic
• Usability Insights (Revenue, USD Bn, 2026 - 2033)
  • Disposable
  • Reusable
• Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
  • Intravenous
  • Intramuscular
  • Subcutaneous
• End User Insights (Revenue, USD Bn, 2026 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • Becton, Dickinson and Company
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Gerresheimer AG
  • Carl-Zeiss-Stiftung
  • Terumo Corporation
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • SHL Group
  • Owen Mumford Limited
  • Injex Pharma GmbH

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Injectable Drug Delivery Market, By Device Type
  • Global Injectable Drug Delivery Market, By Material Type
  • Global Injectable Drug Delivery Market, By Usability
  • Global Injectable Drug Delivery Market, By Route of Administration
  • Global Injectable Drug Delivery Market, By End User
  • Global Injectable Drug Delivery Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Injectable Drug Delivery Market, By Device Type, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Prefilled Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Auto Injectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Pens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Conventional Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Cartridges
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Ampoules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Injectable Drug Delivery Market, By Material Type, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Glass
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Plastic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Injectable Drug Delivery Market, By Usability, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Disposable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Reusable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

7. Global Injectable Drug Delivery Market, By Route of Administration, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Subcutaneous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

8. Global Injectable Drug Delivery Market, By End User, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

9. Global Injectable Drug Delivery Market, By Region, 2020 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novo Nordisk A/S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Gerresheimer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carl-Zeiss-Stiftung
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vetter Pharma-Fertigung GmbH & Co. KG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SHL Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Owen Mumford Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Injex Pharma GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us